Inactive Instrument
Cyprotex plc Share Price London S.E.
Stocks
GB00BP25RZ14
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Madden
COO | Chief Operating Officer | 60 | 27/03/2023 |
| Corporate Secretary | - | 25/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Madden
BRD | Director/Board Member | 60 | 27/03/2023 |
Dirk Ullmann
BRD | Director/Board Member | 60 | 31/12/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.30% | +7.27% | -4.99% | +2.64% | 46.2B | |
| +2.19% | +11.71% | +393.31% | +580.42% | 38.71B | |
| +2.53% | +13.93% | +21.38% | -12.81% | 31.9B | |
| +1.65% | +3.61% | +16.04% | +55.62% | 31.12B | |
| -4.16% | -2.58% | +8.94% | +25.31% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +69.64% | +130.07% | 15.05B | |
| -1.48% | +7.03% | +12.41% | +20.25% | 13.74B | |
| +3.63% | +9.53% | +103.97% | +98.73% | 13.42B | |
| Average | +0.81% | +9.14% | +77.59% | +112.53% | 25.57B | |
| Weighted average by Cap. | +0.98% | +8.71% | +88.83% | +131.24% |
- Stock Market
- Stocks
- Stock
- Stock
Select your edition
All financial news and data tailored to specific country editions
